When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anifrolumab - Wikipedia

   en.wikipedia.org/wiki/Anifrolumab

   Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. [5][7] It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. [medical citation needed] Anifrolumab was approved for medical use in the United ...

3. Lupus - Wikipedia

   en.wikipedia.org/wiki/Lupus

   Lupus. Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [1] Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ...

4. Lupus erythematosus - Wikipedia

   en.wikipedia.org/wiki/Lupus_erythematosus

   Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints, skin, kidneys, blood cells, heart, and lungs. The most common and most severe form is systemic lupus erythematosus.

5. Biogen-UCB's lupus drug meets main goal of late-stage trial - AOL

   www.aol.com/news/biogen-ucbs-lupus-drug-meets...

   September 24, 2024 at 1:04 AM. By Manas Mishra. (Reuters) - Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in patients ...

6. Scientists say they have identified lupus' root cause — and ...

   www.aol.com/news/scientists-identified-lupus...

   The Centers for Disease Control and Prevention estimates that more than 200,000 people in the U.S. have lupus, though the Lupus Foundation of America puts the total much higher: roughly 1.5 ...

7. Belimumab - Wikipedia

   en.wikipedia.org/wiki/Belimumab

   Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]